MEDPRIN REGENERATIMEDPRIN REGENERATIMEDPRIN REGENERATI

MEDPRIN REGENERATI

No trades
See on Supercharts

301033 fundamentals

MEDPRIN REGENERATI financial statements, including revenue, expenses, profit, and loss

The total revenue of 301033 for the last quarter is 67.56 M CNY, and it's 6.01% higher compared to the previous quarter. The net income of Q3 24 is 20.41 M CNY.

Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CNY
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth